Ceritinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Ceritinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. Your doctor will test for the presence of this gene. Ceritinib is an antineoplastic (cancer) agent.Ceritinib Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Ceritinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)-N-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of Ceritinib Nitroso Impurity 2 . We supply Ceritinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141491 |
| CAS No | NA |
| Mol.F. | C12H13ClN2O |
| Mol.Wt. | 236.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141492 |
| CAS No | NA |
| Mol.F. | C12H13ClN2O |
| Mol.Wt. | 236.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141493 |
| CAS No | NA |
| Mol.F. | C20H19N5O3 |
| Mol.Wt. | 377.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141494 |
| CAS No | NA |
| Mol.F. | C34H26Cl2N8O3 |
| Mol.Wt. | 665.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141495 |
| CAS No | NA |
| Mol.F. | C17H14ClN5O2 |
| Mol.Wt. | 355.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141496 |
| CAS No | NA |
| Mol.F. | C21H19N3O9 |
| Mol.Wt. | 457.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141497 |
| CAS No | NA |
| Mol.F. | C21H21N3O10 |
| Mol.Wt. | 475.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141498 |
| CAS No | NA |
| Mol.F. | C22H22N2O9 |
| Mol.Wt. | 458.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141499 |
| CAS No | NA |
| Mol.F. | C16H14ClN7O4 |
| Mol.Wt. | 403.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141500 |
| CAS No | NA |
| Mol.F. | C19H28ClN3O11 |
| Mol.Wt. | 509.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141501 |
| CAS No | NA |
| Mol.F. | C16H14ClN7O4 |
| Mol.Wt. | 403.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141502 |
| CAS No | NA |
| Mol.F. | C16H15ClN2O4 |
| Mol.Wt. | 334.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141503 |
| CAS No | NA |
| Mol.F. | C15H20N4O2 |
| Mol.Wt. | 288.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141504 |
| CAS No | NA |
| Mol.F. | C16H16N2O5 |
| Mol.Wt. | 316.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141505 |
| CAS No | NA |
| Mol.F. | C21H23N3O3S |
| Mol.Wt. | 397.5 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141506 |
| CAS No | NA |
| Mol.F. | C22H23N3O3S |
| Mol.Wt. | 409.5 |
| INV STATUS | CUSTOM SYNTHESIS |